PHI with Aortocoronary venous bypass (Coronary Artery Bypass Grafting with Vein)
How does this condition affect your private health insurance?
Aorto-koronarer Venenbypass, commonly known as Coronary Artery Bypass Grafting (CABG) using a vein, is a surgical procedure to restore blood flow to the heart muscle when coronary arteries are severely narrowed or blocked. A healthy blood vessel, often a saphenous vein from the leg, is grafted to create a new path around the blocked section, allowing blood to bypass the obstruction and reach the heart. This intervention aims to alleviate symptoms like angina, improve heart function, and reduce the risk of heart attack, significantly enhancing the patient's quality of life and prognosis for chronic coronary artery disease.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks (acute recovery from surgery), followed by ongoing management of chronic coronary artery disease.
Duration of Illness (Lifetime)
Chronic disease requiring lifelong management, though the bypass provides significant relief for 10-15+ years.
Cost of Treatment (Initial)
High (e.g., $50,000 - $150,000+ for surgery and initial hospital stay, depending on region and complexity).
Cost of Treatment (Lifetime)
Very high (includes initial surgery, lifelong medications, follow-up appointments, potential future interventions like repeat bypass or stents).
Mortality Rate
Low (typically 1-3% for elective procedures, higher for emergencies or patients with significant comorbidities).
Risk of Secondary Damages
Moderate (e.g., 5-10% for complications such as stroke, infection, kidney failure, arrhythmias, or reoperation for bleeding).
Probability of Full Recovery
Moderate to High (while the underlying CAD is chronic, complete recovery from the surgery with significant symptom improvement is high, typically 80-90%).
Underlying Disease Risk
Very High (coronary artery disease is strongly associated with hypertension, hyperlipidemia, diabetes mellitus, obesity, and peripheral artery disease).